Patient Specific Directions (PSDs) and Patient Group Directions (PGDs)
A Patient Specific Direction (PSD) is a written instruction, signed by a prescriber for medicines to be supplied and/or administered to a named patient after the prescriber has assessed the patient on an individual basis.
In practice, a PSD may be referred to as a “prescription” by those who write and follow them because this indicates that it is written by a prescriber. However, this should not be confused with an FP10 or other written prescription given to the patient for supply from a pharmacy or dispensary. The state that these directions must be written and that a verbal instruction is not a valid PSD.
In exceptional circumstances, where medication has been previously prescribed and the prescriber is unable to issue a new prescription, but where changes to the dose are considered necessary, the use of information technology (such as fax, text message or email) may be used but must confirm any change to the original prescription. Find out more by reading the Royal Pharmaceutical's
Where a verbal instruction is given to alter the dose of a medicine previously prescribed, there would need to be a clear record of the discussion rational and treatment actions carried out documented in the clinical record.
Patient Group Directions (PGDs)
PGDs are written instructions for the supply or administration of medicines to groups of patients who may not be individually identified before presentation for treatment.'
There is guidance from the Specialist Pharmacy Service on storage of PGDs, see: . Also, for guidance on when PGDs are not appropriate and should not be used, see: .
PGDs provide a legal framework that allows the supply and/or administration of a specified medicine(s), to a pre-defined group of patients needing prophylaxis or treatment for a condition described in the PGD, without the need for a prescription or an instruction from a prescriber. Using a PGD is not a form of prescribing. PGDs need to include the name of the authorised, registered health professional using them.
PGDs can only be used by those health care professionals listed in the . Nursing Associates are currently not included so cannot operate under a PGD See the Specialist Pharmacy Services guidance.
The supply and/or administering of medicines under PGDs should be reserved for situations in which this offers an advantage for patient care, without compromising patient safety. Organisations should have policies and processes in place to consider all options before a service is designed or commissioned using PGDs. Before a PGD is developed, the organisation must ensure that PGDs are appropriate, legal and that relevant governance arrangements are in place. There is guidance from the Specialist Pharmacy Service gives advice on storage of PGDs, see: .
Useful resources
- Royal Pharmaceutical Society (2019)
- Royal Pharmaceutical Society (2019)
- National Institute for Health and Care Excellence (NICE) has published a.
- BMA has updated their guidance for . This guidance is for England only.
- CQC on Patient Group Directions and Patient Specific Directions
- regulates medicines, medical devices and blood components for transfusion in the UK.
- is vital in helping the MHRA monitor the safety of all healthcare products in the UK to ensure they are acceptably safe for patients and users. Reports can be made for all medicines including vaccines, and all medical devices available on the UK market.
- Specialist Pharmacy Service.. This includes written instruction templates for adoption.
- Specialist Pharmacy Service. . Understanding when PGDs are an unsuitable mechanism for the supply and/or administration of medicines ensures an alternative legal framework is applied.
- Specialist Pharmacy Service. .
- Specialist Pharmacy Service. .
- Specialist Pharmacy Service.
Patient group direction templates
See the RCN's information on the role of health care support workers and administration of specific vaccines:
Page last updated - 08/10/2024
